BackgroundCheck.run
Search For

David R Blonski, 666634 Chadwick Dr, Prior Lake, MN 55378

David Blonski Phones & Addresses

6634 Chadwick Dr, Savage, MN 55378   

9724 14Th St, Kenosha, WI 53144    262-8592194   

Somers, WI   

Racine, WI   

3150 44Th St, Milwaukee, WI 53219    414-3271213   

Mentions for David R Blonski

David Blonski resumes & CV records

Resumes

David Blonski Photo 25

David Blonski

Location:
6634 Chadwick Dr, Savage, MN 55378
Industry:
Medical Devices
Work:
Featherstone Compliance Group
Retired
Hospira Jan 1, 2014 - Jan 2017
Director Regulatory Affairs
Ge Healthcare Sep 2011 - Dec 2013
Director Quality Assurance Molecular Imaging
Ge Healthcare May 2005 - Sep 2011
Regulatory Affairs Director
Hospira Mar 2004 - May 2005
Project Manager, Pmp
Abbott Mar 1983 - May 2004
R and D Project Manager
Education:
Winona State University 1976 - 1981
Bachelors, Bachelor of Science
Skills:
Iso13485, 21Cfr820, 21Cfr Subchapter J, Team Leadership, Mentoring, Regulatory Affairs, Regulatory Submissions, Quality System, Quality Assurance, Medical Devices, Molecular Imaging, X Ray, Fda, Fda Gmp, Positron Emission Tomography, Design Control, 21 Cfr, Quality Auditing, V&V, Regulatory Requirements, Hardware Diagnostics, Validation, R&D, Iso 13485, Capa, Cross Functional Team Leadership, Six Sigma, Ce Marking, Gmp, 21 Cfr Part 11, Quality Management, Dmaic, Iso 14971, Process Improvement, Change Control, Research and Development, U.s. Food and Drug Administration, Verification and Validation, Business Process Improvement, Corrective and Preventive Action
Interests:
Education
David Blonski Photo 26

David Blonski

Publications & IP owners

Us Patents

Stable Aqueous Fk506 Standards

US Patent:
5338684, Aug 16, 1994
Filed:
Jun 2, 1993
Appl. No.:
8/071942
Inventors:
Frank C. Grenier - Libertyville IL
Julie A. Luczkiw - Addison IL
Merry E. Bergmann - Lombard IL
David R. Blonski - Kenosha WI
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
G01N 3100
US Classification:
436 8
Abstract:
A stabilized, aqueous composition containing FK506. FK506 degrades rapidly in most aqueous matrices. The rate of degradation is decreased in the presence of unfixed blood cells or fragments of blood cells from human or animal sources. A number of matrices using blood components are possible. Blood can be used directly or the blood cells can be lysed. The blood is diluted with a solution of an alkali halide.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.